Data / Drug companies / Dextromethorphan hbr, guaifenesin, phenylephrine hcl
Dextromethorphan hbr, guaifenesin, phenylephrine hcl: 28 companies and 44 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Dextromethorphan hbr, guaifenesin, phenylephrine hcl is listed in the FDA National Drug Code Directory by 28 companies, with 44 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are liquid; solution; tablet, film coated, and the newest product started marketing on July 14, 2026.
The request: Get every company that lists dextromethorphan hbr, guaifenesin, phenylephrine hcl in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 28
- Products
- 44
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Mucus Relief Severe Congestion and Cough Maximum Strength, Severe Congestion and Cough, Mucus Relief Severe Congestion and Cough, Severe Congestion and Cough Max, Tusnel DM, Walgreen Maximum Strength Severe Congestion and Cough, Multi-Symptom Cold Childrens, Tusnel Pediatric DM
- openFDA record search
- api.fda.gov
Companies that list dextromethorphan hbr, guaifenesin, phenylephrine hcl
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Walgreen Company | 5 | solution; liquid | Over the counter monograph drugs | November 25, 2024 |
| CVS Pharmacy | 3 | solution | Over the counter monograph drugs | November 17, 2020 |
| Llorens Pharmaceutical International Division, Inc. | 3 | liquid; solution/ drops | Over the counter monograph drugs | August 1, 2019 |
| Valu Merchandisers Company | 3 | solution; liquid | Over the counter monograph drugs | January 1, 2025 |
| Chain Drug Marketing Association, Inc. | 2 | liquid; solution | Over the counter monograph drugs | September 15, 2025 |
| Family Dollar (family Wellness) | 2 | solution | Over the counter monograph drugs | November 26, 2024 |
| Guardian Drug Company | 2 | liquid | Over the counter monograph drugs | December 1, 2012 |
| Menper Distributors, Inc. | 2 | liquid | Over the counter monograph drugs | November 1, 2024 |
| Topco Associates LLC | 2 | solution | Over the counter monograph drugs | March 7, 2024 |
| Walmart Inc. | 2 | solution; liquid | Over the counter monograph drugs | November 14, 2024 |
| Actipharma, LLC | 1 | solution | Over the counter monograph drugs | May 20, 2019 |
| Advanced Generic Corporation | 1 | liquid | Over the counter monograph drugs | December 1, 2024 |
| Alternative Pharmacal Corporation | 1 | liquid | Over the counter monograph drugs | May 1, 2013 |
| AptaPharma Inc. | 1 | liquid | Over the counter monograph drugs | January 30, 2024 |
| CVS Pharmacy | 1 | tablet, film coated | Over the counter monograph drugs | July 20, 2015 |
| CVS Woonsocket Prescription Center, Incorporated | 1 | liquid | Over the counter monograph drugs | January 16, 2025 |
| Cardinal Health 110, LLC. DBA Leader | 1 | liquid | Over the counter monograph drugs | March 15, 2023 |
| Efficient Laboratories Inc | 1 | liquid | Over the counter monograph drugs | October 1, 2007 |
| Genomma Lab USA | 1 | liquid | Over the counter monograph drugs | December 16, 2016 |
| Gil Pharmaceutical Corp | 1 | tablet | Over the counter monograph drugs | April 1, 2021 |
| HyVee Inc | 1 | liquid | Over the counter monograph drugs | July 14, 2026 |
| Perrigo Direct, Inc | 1 | liquid | Over the counter monograph drugs | November 5, 2024 |
| Pharmadel LLC | 1 | liquid | Over the counter monograph drugs | September 3, 2020 |
| Raritan Pharmaceuticals Inc | 1 | liquid | Over the counter monograph drugs | February 5, 2019 |
| Topco Associates LLC | 1 | liquid | Over the counter monograph drugs | February 28, 2015 |
| United Natural Foods, Inc. DBA Unfi | 1 | liquid | Over the counter monograph drugs | November 30, 2014 |
| Wal-Mart Stores Inc | 1 | liquid | Over the counter monograph drugs | October 1, 2014 |
| WinCo Foods, LLC | 1 | liquid | Over the counter monograph drugs | December 31, 2014 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 25 | 56.8% |
| Solution | 15 | 34.1% |
| Tablet, film coated | 2 | 4.5% |
| Tablet | 1 | 2.3% |
| Solution/ drops | 1 | 2.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 44 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Expectorant | 44 |
| Sigma-1 Agonist | 44 |
| Uncompetitive N-methyl-D-aspartate Receptor Antagonist | 44 |
| alpha-1 Adrenergic Agonist | 43 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.